Clinical evaluation of nuclear matrix protein 22 (NMP22) in urine as a novel marker for urothelial cancer

European Urology

Volumn 31, Issue 2, 1997, Pages 163-168

  Miyanaga, N ^a   Akaza, H ^a   Ishikawa, S ^a   Ohtani, M ^a   Noguchi, R ^a   Kawai, K ^a   Koiso, K ^a   Kobayashi, M ^a   Koyama, A ^a   Takahashi, T ^a  

^a UNIVERSITY OF TSUKUBA   (Japan)

Author keywords

Apoptosis; NMP22; Tumor recurrence; Urine marker; Urothelial cancer; Voided urine cytology

Indexed keywords

NUCLEAR MATRIX PROTEIN 22; NUCLEAR PROTEIN; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; AGED; ARTICLE; CELL NUCLEUS MATRIX; CHILD; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CYTODIAGNOSIS; DIAGNOSTIC ACCURACY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; URINARY TRACT CANCER; URINARY TRACT INFECTION; URINE CYTOLOGY; URINE LEVEL;

EID: 0031054459     PISSN: 03022838     EISSN: None     Source Type: Journal    
DOI: 10.1159/000474443     Document Type: Article

References (21)